메뉴 건너뛰기




Volumn 3, Issue 2, 2009, Pages 193-205

MammaPrint 70-gene profile quantifies the likelihood of recurrence for early breast cancer

Author keywords

Breast cancer; Gene expression profile; MammaPrint; Metastasis; MINDACT; Prognosis

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; HOX PROTEIN; INTERLEUKIN 17; LETROZOLE; RNA; TAMOXIFEN;

EID: 77953474687     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530050902751618     Document Type: Review
Times cited : (11)

References (55)
  • 2
    • 33847638137 scopus 로고    scopus 로고
    • Estimates of the cancer incidence and mortality in Europe in 2006
    • Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18(3):581-592
    • (2007) Ann Oncol , vol.18 , Issue.3 , pp. 581-592
    • Ferlay, J.1    Autier, P.2    Boniol, M.3
  • 3
    • 34247241630 scopus 로고    scopus 로고
    • The decrease in breast-cancer incidence in 2003 in the United States
    • Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356(16):1670-1674
    • (2007) N Engl J Med , vol.356 , Issue.16 , pp. 1670-1674
    • Ravdin, P.M.1    Cronin, K.A.2    Howlader, N.3
  • 4
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • EBCTCG EBCTCG
    • EBCTCG) EBCTCG. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687-1717
    • (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717
  • 5
    • 33644895704 scopus 로고    scopus 로고
    • Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000
    • Harlan LC, Clegg LX, Abrams J, et al. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol 2006;24(6):872-877
    • (2006) J Clin Oncol , vol.24 , Issue.6 , pp. 872-877
    • Harlan, L.C.1    Clegg, L.X.2    Abrams, J.3
  • 6
    • 33747400905 scopus 로고    scopus 로고
    • Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer
    • Hassett MJ, O'Malley AJ, Pakes JR, et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 2006;98(16):1108-1117
    • (2006) J Natl Cancer Inst , vol.98 , Issue.16 , pp. 1108-1117
    • Hassett, M.J.1    O'Malley, A.J.2    Pakes, J.R.3
  • 7
    • 36849069347 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    • Harris L. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25:5287-5312
    • (2007) J Clin Oncol , vol.25 , pp. 5287-5312
    • Harris, L.1
  • 8
    • 0035865149 scopus 로고    scopus 로고
    • Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
    • Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001;19(4):980-991
    • (2001) J Clin Oncol , vol.19 , Issue.4 , pp. 980-991
    • Ravdin, P.M.1    Siminoff, L.A.2    Davis, G.J.3
  • 9
    • 18444383684 scopus 로고    scopus 로고
    • Population-based validation of the prognostic model ADJUVANT! for early breast cancer
    • Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005;23(12):2716-2725
    • (2005) J Clin Oncol , vol.23 , Issue.12 , pp. 2716-2725
    • Olivotto, I.A.1    Bajdik, C.D.2    Ravdin, P.M.3
  • 10
    • 0035949684 scopus 로고    scopus 로고
    • Predicting the clinical status of human breast cancer by using gene expression profiles
    • West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001;98(20):11462-11467
    • (2001) Proc Natl Acad Sci USA , vol.98 , Issue.20 , pp. 11462-11467
    • West, M.1    Blanchette, C.2    Dressman, H.3
  • 11
    • 19944422061 scopus 로고    scopus 로고
    • A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    • Paik S. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-2826
    • (2004) N Engl J Med , vol.351 , pp. 2817-2826
    • Paik, S.1
  • 12
    • 0037478605 scopus 로고    scopus 로고
    • Repeated observation of breast tumor subtypes in independent gene expression data sets
    • Sorlie T. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-8423
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 8418-8423
    • Sorlie, T.1
  • 13
    • 33144462268 scopus 로고    scopus 로고
    • Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
    • Sotiriou C, Wirapati P, Loi S, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006;98(4):262-272
    • (2006) J Natl Cancer Inst , vol.98 , Issue.4 , pp. 262-272
    • Sotiriou, C.1    Wirapati, P.2    Loi, S.3
  • 14
    • 18244409687 scopus 로고    scopus 로고
    • Gene expression profiling predicts clinical outcome of breast cancer
    • van't Veer LJ. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536
    • (2002) Nature , vol.415 , pp. 530-536
    • Van't Veer, L.J.1
  • 15
    • 13844310310 scopus 로고    scopus 로고
    • Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
    • Wang Y. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671-679
    • (2005) Lancet , vol.365 , pp. 671-679
    • Wang, Y.1
  • 16
    • 0035072249 scopus 로고    scopus 로고
    • Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer
    • Hughes TR, Mao M, Jones AR, et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat biotechnol 2001;19(4):342-347
    • (2001) Nat Biotechnol , vol.19 , Issue.4 , pp. 342-347
    • Hughes, T.R.1    Mao, M.2    Jones, A.R.3
  • 17
    • 0035884636 scopus 로고    scopus 로고
    • Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer
    • Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001;19(18):3817-3827
    • (2001) J Clin Oncol , vol.19 , Issue.18 , pp. 3817-3827
    • Goldhirsch, A.1    Glick, J.H.2    Gelber, R.D.3
  • 18
    • 0035806484 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000
    • Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93(13):979-989
    • (2001) J Natl Cancer Inst , vol.93 , Issue.13 , pp. 979-989
    • Eifel, P.1    Axelson, J.A.2    Costa, J.3
  • 19
    • 33748693297 scopus 로고    scopus 로고
    • Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
    • Buyse M, Loi S, van't Veer L, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98(17):1183-1192
    • (2006) J Natl Cancer Inst , vol.98 , Issue.17 , pp. 1183-1192
    • Buyse, M.1    Loi, S.2    Van't Veer, L.3
  • 20
    • 0023203185 scopus 로고
    • Confirmation of a prognostic index in primary breast cancer
    • Todd JH, Dowle C, Williams MR, et al. Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987;56(4):489-492
    • (1987) Br J Cancer , vol.56 , Issue.4 , pp. 489-492
    • Todd, J.H.1    Dowle, C.2    Williams, M.R.3
  • 21
    • 32244435355 scopus 로고    scopus 로고
    • Mechanisms of trastuzumab resistance and their clinical implications
    • Lan KH, Lu CH, Yu D. Mechanisms of trastuzumab resistance and their clinical implications. Ann NY Acad Sci 2005;1059:70-75
    • (2005) Ann NY Acad Sci , vol.1059 , pp. 70-75
    • Lan, K.H.1    Lu, Ch.2    Yu, D.3
  • 22
    • 36549011637 scopus 로고    scopus 로고
    • A new independent validation of the 70-gene signature in node-negative breast cancer
    • Bueno de Mesquita JM, Keijzer R, Linn SC, et al. A new independent validation of the 70-gene signature in node-negative breast cancer. Eur J Cancer Suppl 2006;4(2):131
    • (2006) Eur J Cancer Suppl , vol.4 , Issue.2 , pp. 131
    • Bueno De Mesquita, J.M.1    Keijzer, R.2    Linn, S.C.3
  • 23
    • 67649183386 scopus 로고    scopus 로고
    • The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study
    • Epub Ahead of Print (doi: 10.1007/s10549-008-0130-2)
    • Mook S, Schmidt MK, Viale G, et al. The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat 2008. Epub Ahead of Print (doi: 10.1007/s10549-008-0130-2)
    • (2008) Breast Cancer Res Treat
    • Mook, S.1    Schmidt, M.K.2    Viale, G.3
  • 24
    • 34547852275 scopus 로고    scopus 로고
    • Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007
    • Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007;18(7):1133-1144
    • (2007) Ann Oncol , vol.18 , Issue.7 , pp. 1133-1144
    • Goldhirsch, A.1    Wood, W.C.2    Gelber, R.D.3
  • 25
    • 33751193656 scopus 로고    scopus 로고
    • Converting a breast cancer microarray signature into a high-throughput diagnostic test
    • Glas AM, Floore A, Delahaye LJ, et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 2006;7:278
    • (2006) BMC Genomics , vol.7 , pp. 278
    • Glas, A.M.1    Floore, A.2    Delahaye, L.J.3
  • 26
    • 34347395753 scopus 로고    scopus 로고
    • Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools
    • Ach RA, Floore A, Curry B, et al. Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools. BMC Genomics 2007;8:148
    • (2007) BMC Genomics , vol.8 , pp. 148
    • Ach, R.A.1    Floore, A.2    Curry, B.3
  • 28
    • 0037137519 scopus 로고    scopus 로고
    • A gene-expression signature as a predictor of survival in breast cancer
    • van de Vijver MJ. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009
    • (2002) N Engl J Med , vol.347 , pp. 1999-2009
    • Van De Vijver, M.J.1
  • 30
    • 39149123547 scopus 로고    scopus 로고
    • Clinical application of the 70-gene profile: The MINDACT trial
    • Cardoso F, Van't Veer L, Rutgers E, et al. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol 2008;26(5):729-735
    • (2008) J Clin Oncol , vol.26 , Issue.5 , pp. 729-735
    • Cardoso, F.1    Van't Veer, L.2    Rutgers, E.3
  • 31
    • 33750601244 scopus 로고    scopus 로고
    • Gene signature evaluation as a prognostic tool: Challenges in the design of the MINDACT trial
    • Bogaerts J, Cardoso F, Buyse M, et al. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nat Clin Pract 2006;3(10):540-551
    • (2006) Nat Clin Pract , vol.3 , Issue.10 , pp. 540-551
    • Bogaerts, J.1    Cardoso, F.2    Buyse, M.3
  • 32
    • 34249311296 scopus 로고    scopus 로고
    • Individualization of therapy using MammaPrint: From development to the MINDACT Trial
    • Mook S. Individualization of therapy using MammaPrint: from development to the MINDACT Trial. Cancer Genomics Proteomics 2007;4:147-155
    • (2007) Cancer Genomics Proteomics , vol.4 , pp. 147-155
    • Mook, S.1
  • 33
    • 32944463609 scopus 로고    scopus 로고
    • Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy
    • Paik S. Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy. Clin Cancer Res 2006;12(3 Pt 2):1019s-23s
    • (2006) Clin Cancer Res , vol.12 , Issue.3 PART 2
    • Paik, S.1
  • 34
    • 33744808550 scopus 로고    scopus 로고
    • A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
    • Habel LA, Shak S, Jacobs MK, et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res 2006;8(3):R25
    • (2006) Breast Cancer Res , vol.8 , Issue.3
    • Habel, L.A.1    Shak, S.2    Jacobs, M.K.3
  • 35
    • 33744814477 scopus 로고    scopus 로고
    • Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    • Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726-3734
    • (2006) J Clin Oncol , vol.24 , Issue.23 , pp. 3726-3734
    • Paik, S.1    Tang, G.2    Shak, S.3
  • 36
    • 51349107911 scopus 로고    scopus 로고
    • Comparison of prognostic gene expression signatures for breast cancer
    • Haibe-Kains B, Desmedt C, Piette F, et al. Comparison of prognostic gene expression signatures for breast cancer. BMC Genomics 2008;9:394
    • (2008) BMC Genomics , vol.9 , pp. 394
    • Haibe-Kains, B.1    Desmedt, C.2    Piette, F.3
  • 37
    • 2942578063 scopus 로고    scopus 로고
    • A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
    • Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004;5(6):607-616
    • (2004) Cancer Cell , vol.5 , Issue.6 , pp. 607-616
    • Ma, X.J.1    Wang, Z.2    Ryan, P.D.3
  • 38
    • 33750598939 scopus 로고    scopus 로고
    • The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer
    • Ma XJ. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 2006;24:4611-4619
    • (2006) J Clin Oncol , vol.24 , pp. 4611-4619
    • Ma, X.J.1
  • 39
    • 52049095087 scopus 로고    scopus 로고
    • A Five-Gene Molecular Grade Index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer
    • Ma XJ, Salunga R, Dahiya S, et al. A Five-Gene Molecular Grade Index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res 2008;14(9):2601-2608
    • (2008) Clin Cancer Res , vol.14 , Issue.9 , pp. 2601-2608
    • Ma, X.J.1    Salunga, R.2    Dahiya, S.3
  • 40
    • 51349088017 scopus 로고    scopus 로고
    • Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
    • Desmedt C, Haibe-Kains B, Wirapati P, et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 2008;14(16):5158-5165
    • (2008) Clin Cancer Res , vol.14 , Issue.16 , pp. 5158-5165
    • Desmedt, C.1    Haibe-Kains, B.2    Wirapati, P.3
  • 41
    • 33746910265 scopus 로고    scopus 로고
    • Concordance among gene-expression-based predictors for breast cancer
    • Fan C. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006;355:560-569
    • (2006) N Engl J Med , vol.355 , pp. 560-569
    • Fan, C.1
  • 42
    • 70249137524 scopus 로고    scopus 로고
    • Combined use of genomic prognostic and treatment response predictors in breast cancer
    • abstract 527
    • Pusztai LH, Hatzis C, Cardoso F, et al. Combined use of genomic prognostic and treatment response predictors in breast cancer [abstract 527]. J Clin Oncol 2008;26(Suppl)
    • (2008) J Clin Oncol , vol.26 , Issue.SUPPL.
    • Pusztai, L.H.1    Hatzis, C.2    Cardoso, F.3
  • 43
    • 34250652449 scopus 로고    scopus 로고
    • Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
    • Desmedt C. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007;13:3207-3214
    • (2007) Clin Cancer Res , vol.13 , pp. 3207-3214
    • Desmedt, C.1
  • 44
    • 0038488950 scopus 로고    scopus 로고
    • A multigenic program mediating breast cancer metastasis to bone
    • Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer cell 2003;3(6):537-549
    • (2003) Cancer Cell , vol.3 , Issue.6 , pp. 537-549
    • Kang, Y.1    Siegel, P.M.2    Shu, W.3
  • 45
    • 33744813556 scopus 로고    scopus 로고
    • Genes associated with breast cancer metastatic to bone
    • Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol 2006;24(15):2261-2267
    • (2006) J Clin Oncol , vol.24 , Issue.15 , pp. 2261-2267
    • Smid, M.1    Wang, Y.2    Klijn, J.G.3
  • 46
    • 23144461051 scopus 로고    scopus 로고
    • Genes that mediate breast cancer metastasis to lung
    • Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436(7050):518-524
    • (2005) Nature , vol.436 , Issue.7050 , pp. 518-524
    • Minn, A.J.1    Gupta, G.P.2    Siegel, P.M.3
  • 47
    • 68949149330 scopus 로고    scopus 로고
    • Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts)
    • abstract 1019
    • Duchnowska RJJ, Thorat MA, Morimiya A, et al. Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts) [abstract 1019]. J Clin Oncol 2008;26(Suppl)
    • (2008) J Clin Oncol , vol.26 , Issue.SUPPL.
    • Duchnowska, R.J.J.1    Thorat, Ma.2    Morimiya, A.3
  • 48
    • 0042125511 scopus 로고    scopus 로고
    • Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
    • Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362(9381):362-369
    • (2003) Lancet , vol.362 , Issue.9381 , pp. 362-369
    • Chang, J.C.1    Wooten, E.C.2    Tsimelzon, A.3
  • 49
    • 20044377912 scopus 로고    scopus 로고
    • Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling
    • Jansen MPHM, Foekens JA, van Staveren IL, et al. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol 2005;23(4):732-740
    • (2005) J Clin Oncol , vol.23 , Issue.4 , pp. 732-740
    • Mphm, J.1    Foekens, J.A.2    Van Staveren, I.L.3
  • 50
    • 59149101766 scopus 로고    scopus 로고
    • Identification of a 6 gene molecular predictor of lapatinib related benefit: From breast cancer cell lines to a phase III trial
    • abstract 1043
    • Gray JW, Das D, Wang N, et al. Identification of a 6 gene molecular predictor of lapatinib related benefit: From breast cancer cell lines to a phase III trial [abstract 1043]. J Clin Oncol 2008;(Suppl)
    • (2008) J Clin Oncol , Issue.SUPPL.
    • Gray, J.W.1    Das, D.2    Wang, N.3
  • 52
    • 71749117906 scopus 로고    scopus 로고
    • Available from: [cited 3 October 2008]
    • GenomicHealth. The Role of Oncotype DX. Available from: http://www.genomichealth.com/oncotype/role/default.aspx. 2008 [cited 3 October 2008]
    • (2008) The Role of Oncotype DX
  • 53
    • 77953391810 scopus 로고    scopus 로고
    • Available from: [cited 3 October 2008]
    • Ipsogen. Improving the clinical value of tumor grading. Available from: http://www.ipsogen.com/breast-cancer-products/healthcare-professionnals/ mapquant-dxgenomicgrade/. 2008 [cited 3 October 2008]
    • (2008) Improving the Clinical Value of Tumor Grading


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.